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INTRODUCTION
Spermatocytic seminoma (SCS) is an uncommon germ cell tumor which accounts for 1%-2% of all testicular tumors. [1] It is a slow-growing tumor presenting after the 5 th decade of life with a favorable outcome. [1] The presence of sarcomatous component converts this otherwise slow growing, localized, indolent neoplasm into a rapidly growing, infiltrative, aggressive tumor with metastatic potential, and poor prognosis. Identification of this component is very crucial for proper management. The development of rhabdomyosarcoma in SCS is extremely rare with eight cases having been reported till date, with only two earlier case reports from India. [2, 3] 
CASE REPORT
A 60-year-old male presented with a painless, slowly enlarging right testicular mass of 4 years' duration with a rapid increase in the size for 2 months. There was no history of smoking or any drug intake. Clinical examination revealed a nontender enlarged right testis. There were no palpable inguinal lymph nodes. Ultrasonography revealed a large lobulated mass in the right testis measuring 18 cm × 8 cm × 7 cm which showed heterogeneous echogenicity with necrotic areas [ Figure 1a ]. Computed tomography of abdomen and pelvis and X-ray chest did not reveal any metastatic or lymphatic involvement. Serum tumor markers beta human chorionic gonadotropin, alpha-fetoprotein (AFP), and lactate dehydrogenase were normal. The patient underwent right inguinal orchidectomy. On gross examination, a large lobulated tumor measuring 18 cm × 7.5 cm × 6.3 cm in size was seen replacing the entire right testis [ Figure 1b ]. On cut section, the tumor was gray-white with a heterogeneous appearance. There were fleshy, glistening, solid areas interrupted by friable necrotic areas. The testicular capsule appeared breached, and epididymis and normal testicular tissue could not be identified. 
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Case Report eccentric nuclei, eosinophilic cytoplasm, and prominent nucleoli were seen [ Figure 2a ]. The sarcomatous component infiltrated the epididymis and spermatic cord, and focally the tunica albuginea [ Figure 2b and c]. These cells stained strongly for Desmin antibody [ Figure 2d ]. No areas of ITCGN or other germ cell component were identified. A diagnosis of SCS with rhabdomyoblastic differentiation was given based on the morphology and IHC studies. Further treatment with adjuvant chemotherapy was advised, but the patient refused the same. Two months' postsurgery, the patient is symptomatically doing well.
DISCUSSION
SCS is an uncommon germ cell neoplasm first described by Masson. [3] The usual age of presentation is in the 5 th or 6 th decade of life as compared with classic seminoma which occurs usually in the age group of 30-40 years. [1, 4] It presents as a slowly growing painless swelling with symptoms ranging from few months to 4 years. Bilateral involvement is seen in 10% of the cases. [1, 2] The diagnosis of SCS is based on the presence of a tripartite population of small lymphocyte-like, intermediate and large cells with filamentous chromatin. Unlike classical seminoma, SCS is not associated with ITGCN or other germ cell components. [1] It is an indolent neoplasm which presents at an early stage with the absence of metastasis and excellent prognosis.
However, in a few cases, sarcomatous transformation occurs in SCS which changes its growth pattern renders the tumor a metastatic potential with poor prognosis. On review of literature, <20 cases of sarcomatous transformation have been reported with three case reports from India. Out of these two cases showed rhabdomyosarcomatous differentiation and one showed the presence of undifferentiated sarcoma [2, 3, 5] The sarcomatous component was rhabdomyosarcoma in 8 of these cases [2] [3] [4] [6] [7] [8] [9] [ Table 1 ]. In majority of the reported cases of SCS with rhabdomyosarcomatous component, the patients were in 5 th or 6 th decade of life with three patients <45 years. [4, 7, 8] The youngest reported case was that of a 38-year-old man Narang et al. [3] The sudden increase in size of a previously slowly growing swelling suggests the emergence of a sarcomatous component. This was also seen in the present case. SCS component was well circumscribed while the sarcomatous component was seen infiltrating into the epididymis and rete testis as has been reported in earlier cases. [2, 3] The sarcomatous component showed the presence of spindle cells intermixed with rhabdomyoblasts which stained positive with desmin stain confirming the diagnosis.
In these cases, it is important not to mistake the epithelial structures of rete testis and epidydimus for an epithelial component of a mixed NSGCT. [2, 5] Metastatic disease at the time of presentation was detected in five cases to distant sites such as lung liver and bone. [3] [4] [5] [6] All of these cases died within a year of diagnosis. Hence, the presence of sarcomatous differentiation in SCS is associated with aggressive behavior presence of metastasis and poor outcome.
The mechanism of this sarcomatous transformation is unknown. One hypothesis is anaplastic conversion of SCS. [3, 6] The rapid growth phase seen clinically probably represents this period of transition and histological differentiation into sarcoma. [3, 6] Another theory is differentiation of totipotent germ cells to somatic tissues and subsequent malignant transformation or by malignant transformation of a preexisting teratomatous element. [6] The gain of chromosome 9 is the consistent chromosomal anomaly found in SCS. However, chromosomal studies have not been done in the limited reported cases of SCS with rhabdomyosarcomatous differentiation. [8] As very few case reports are available, prognostic factors in SCS with rhabdomyosarcomatous differentiation have not been established. Most cases irrespective of age, site and size showed an aggressive behavior; however, those with extratesticular disease with metastasis had a short survival.
The treatment of choice for SCS is orchidectomy. However, in the presence of sarcomatous component, adjuvant chemotherapy or radiotherapy may be beneficial.
CONCLUSION
SCS with rhabdomyosarcomatous differentiation is an exceptionally rare tumor with only eight cases reported in the literature reported so far. All these cases were reported in patients with a neglected testicular mass over a period of years; therefore, there is a need for early detection and surgical removal. Second, in a few of these cases, majority of the tumor remained well circumscribed with focal infiltration on gross inspection. Hence, a meticulous sampling of the tumor to detect areas of sarcomatous transformation is imperative. Third, these tumors often present with concurrent metastatic disease; and thus, treatment with adjuvant chemotherapy following radical inguinal orchidectomy should be considered in all cases.
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